SLC35F2 and thyroid gland papillary carcinoma: In addition, high levels of SLC35F2 were positively correlated with progression of papillary thyroid carcinoma (PTC) and knockdown of SLC35F2 suppressed the malignant phenotype of PTC cells in vitro and in vivo [14].